1. Home
  2. ENSC vs LIDR Comparison

ENSC vs LIDR Comparison

Compare ENSC & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$1.01

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$2.16

Market Cap

118.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENSC
LIDR
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
118.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ENSC
LIDR
Price
$1.01
$2.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
448.3K
1.4M
Earning Date
11-14-2025
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,487,973.00
$182,000.00
Revenue This Year
N/A
$2.76
Revenue Next Year
N/A
$2,830.58
P/E Ratio
N/A
N/A
Revenue Growth
1.51
N/A
52 Week Low
$0.86
$0.49
52 Week High
$9.31
$6.44

Technical Indicators

Market Signals
Indicator
ENSC
LIDR
Relative Strength Index (RSI) 31.81 45.98
Support Level $0.89 $1.80
Resistance Level $1.24 $2.32
Average True Range (ATR) 0.09 0.13
MACD 0.01 -0.01
Stochastic Oscillator 34.13 55.60

Price Performance

Historical Comparison
ENSC
LIDR

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: